Emerson Briefing Note Axendia was recently briefed by, Kristel Biehler, Vice President Life Sciences at Emerson on the company’s acquisition of Fluxa to strengthen its […]
Managing the Digital Recipe Development Lifecycle Read More »
By: Thomas Maeder, Industry Analyst, Axendia “The United States faces persistent and increasingly sophisticated malicious cyber campaigns that threaten the public sector, the private sector,
Medical Device Cybersecurity Throughout the Product Life Cycle Read More »
Siemens Announcements at the Hannover Messe 2021 – Event Brief By Eric M. Luyer – Industry Research Analyst, Axendia Inc. In these difficult “Corona” times the
Infinite Opportunities from Infinite Data in Life Sciences Read More »
An open Letter to the Life-Sciences Industry on Analyst Forced Vendor Rankings By: Daniel R. Matlis As a Life-Science Industry Analyst, I am often asked
Q: Who is the Best Technology Vendor? A: NONE! Read More »
AVEVA Briefing Note By Daniel R. Matlis Axendia was recently briefed by Craig Hayman, CEO AVEVA and Dr. J. Patrick Kennedy, Founder and Chairman Emeritus
AVEVA to Accelerate Growth in Life Sciences with OSIsoft Acquisition Read More »
Disruptions have eroded trust across Life-Science supply chains forcing brand owners to re-evaluate outsourcing programs in favor of Smart-Sourcing strategies that focus on quality, resilience,
Digital Transformation Builds Trust Across the Value Network Read More »
QbDVision Briefing Note By Daniel R. Matlis The Executive Management team at CherryCircle Software recently briefed Axendia on QbDVision®, its cloud-based Product Quality and Lifecycle
Improving Process Understanding Across the Product Lifecycle Read More »
Automating Electronic Batch Record review is a key benefit of Modernizing Manufacturing Operations. Yet concerns regarding FDA’s acceptance of Review by Exception (RBE) has prevented
FDA Debunks Industry Myths on Electronic Batch Records and Review by Exceptions Read More »
Industry must adapt and overcome current and future disruptive trends on the horizon. To assist in this effort, Axendia revealed the 2021 Life-Sciences Radar. In
2021 Forecast for the Life Sciences Industry Read More »
The FDA has recognized that current perceptions and approaches to computer system validation (CSV) are a significant barrier to Digital Transformation and Manufacturing Modernization. The
FDA Shares Insights on Digital Transformation & Manufacturing Modernization Read More »
By Daniel R. Matlis Sanmina’s Medical Division manufactures a wide range of products and systems for well known medical OEMs including laboratory, biotechnology, diagnostics, therapeutic,
Sanmina Medical Embraces Cloud MES To Optimize Manufacturing Read More »
Tulip Interfaces Briefing Note By: Daniel R. Matlis, President I recently had the opportunity to visit Tulip Interfaces, Inc., HQ in Somerville, MA to see
GxP Ready No-Code PaaS IoT Self-Serve Manufacturing Apps Read More »
